

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * tricarboxylic acid cycle (GO:0006099) | 6.34822709 |
| 2 | lysine catabolic process (GO:0006554) | 5.97040632 |
| 3 | lysine metabolic process (GO:0006553) | 5.97040632 |
| 4 | fatty acid beta-oxidation (GO:0006635) | 5.14481854 |
| 5 | 2-oxoglutarate metabolic process (GO:0006103) | 5.06160057 |
| 6 | NADH metabolic process (GO:0006734) | 5.03419743 |
| 7 | glyoxylate metabolic process (GO:0046487) | 4.89338089 |
| 8 | aspartate family amino acid catabolic process (GO:0009068) | 4.86563099 |
| 9 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.72992676 |
| 10 | carnitine shuttle (GO:0006853) | 4.69731192 |
| 11 | branched-chain amino acid catabolic process (GO:0009083) | 4.63368770 |
| 12 | fatty acid transmembrane transport (GO:1902001) | 4.61994505 |
| 13 | oxidative phosphorylation (GO:0006119) | 4.61972636 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.61110478 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.61110478 |
| 16 | tricarboxylic acid metabolic process (GO:0072350) | 4.56680223 |
| 17 | fatty acid oxidation (GO:0019395) | 4.56522121 |
| 18 | regulation of sequestering of triglyceride (GO:0010889) | 4.51624568 |
| 19 | lipid oxidation (GO:0034440) | 4.47409517 |
| 20 | succinate metabolic process (GO:0006105) | 4.45595894 |
| 21 | fatty acid catabolic process (GO:0009062) | 4.45484947 |
| 22 | short-chain fatty acid metabolic process (GO:0046459) | 4.45310741 |
| 23 | oxaloacetate metabolic process (GO:0006107) | 4.42728126 |
| 24 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.41201686 |
| 25 | branched-chain amino acid metabolic process (GO:0009081) | 4.31932055 |
| 26 | sarcomere organization (GO:0045214) | 4.28833597 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 4.26786059 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.26786059 |
| 29 | acetyl-CoA metabolic process (GO:0006084) | 4.25875211 |
| 30 | * respiratory electron transport chain (GO:0022904) | 4.19380557 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.17880633 |
| 32 | valine metabolic process (GO:0006573) | 4.17810200 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.15434536 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.12980676 |
| 35 | regulation of fatty acid oxidation (GO:0046320) | 4.11504099 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.11166721 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 4.11166721 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09511504 |
| 39 | carnitine metabolic process (GO:0009437) | 4.07127730 |
| 40 | * electron transport chain (GO:0022900) | 4.06959635 |
| 41 | monocarboxylic acid catabolic process (GO:0072329) | 4.01557554 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.97170654 |
| 43 | regulation of cofactor metabolic process (GO:0051193) | 3.95836214 |
| 44 | regulation of coenzyme metabolic process (GO:0051196) | 3.95836214 |
| 45 | cysteine metabolic process (GO:0006534) | 3.90092944 |
| 46 | positive regulation of fatty acid oxidation (GO:0046321) | 3.81997013 |
| 47 | viral transcription (GO:0019083) | 3.81173483 |
| 48 | biotin metabolic process (GO:0006768) | 3.79141912 |
| 49 | kynurenine metabolic process (GO:0070189) | 3.76247377 |
| 50 | alpha-linolenic acid metabolic process (GO:0036109) | 3.75212023 |
| 51 | sulfur amino acid catabolic process (GO:0000098) | 3.71531686 |
| 52 | aromatic amino acid family catabolic process (GO:0009074) | 3.69782872 |
| 53 | translational termination (GO:0006415) | 3.66923553 |
| 54 | amino-acid betaine transport (GO:0015838) | 3.64380322 |
| 55 | carnitine transport (GO:0015879) | 3.64380322 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.62291685 |
| 57 | potassium ion import (GO:0010107) | 3.61116842 |
| 58 | actin-myosin filament sliding (GO:0033275) | 3.60253747 |
| 59 | muscle filament sliding (GO:0030049) | 3.60253747 |
| 60 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.59941030 |
| 61 | carnitine transmembrane transport (GO:1902603) | 3.59922529 |
| 62 | ethanol oxidation (GO:0006069) | 3.58674828 |
| 63 | regulation of triglyceride catabolic process (GO:0010896) | 3.57469405 |
| 64 | ketone body metabolic process (GO:1902224) | 3.56048119 |
| 65 | cardiac myofibril assembly (GO:0055003) | 3.55139619 |
| 66 | organic acid catabolic process (GO:0016054) | 3.46245268 |
| 67 | carboxylic acid catabolic process (GO:0046395) | 3.46245268 |
| 68 | serine family amino acid catabolic process (GO:0009071) | 3.45200987 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.40218603 |
| 70 | response to pheromone (GO:0019236) | 3.39215023 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.39204036 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 3.36854615 |
| 73 | creatine metabolic process (GO:0006600) | 3.36300669 |
| 74 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.32104503 |
| 75 | ribosomal small subunit biogenesis (GO:0042274) | 3.30510055 |
| 76 | indole-containing compound catabolic process (GO:0042436) | 3.25689258 |
| 77 | indolalkylamine catabolic process (GO:0046218) | 3.25689258 |
| 78 | tryptophan catabolic process (GO:0006569) | 3.25689258 |
| 79 | homocysteine metabolic process (GO:0050667) | 3.24674326 |
| 80 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.23750082 |
| 81 | regulation of sulfur metabolic process (GO:0042762) | 3.23198245 |
| 82 | quaternary ammonium group transport (GO:0015697) | 3.22477958 |
| 83 | response to mercury ion (GO:0046689) | 3.22043510 |
| 84 | myofibril assembly (GO:0030239) | 3.20374489 |
| 85 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.19062369 |
| 86 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.18583576 |
| 87 | glycine metabolic process (GO:0006544) | 3.15162001 |
| 88 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.14535885 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 3.08350692 |
| 90 | bile acid biosynthetic process (GO:0006699) | 3.08141869 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.07277731 |
| 92 | NAD metabolic process (GO:0019674) | 3.06339751 |
| 93 | regulation of skeletal muscle contraction (GO:0014819) | 3.04177812 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 3.03868614 |
| 95 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.03741563 |
| 96 | tryptophan metabolic process (GO:0006568) | 3.02789640 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.01987655 |
| 98 | dicarboxylic acid metabolic process (GO:0043648) | 3.01318537 |
| 99 | quinone biosynthetic process (GO:1901663) | 3.00635746 |
| 100 | ubiquinone biosynthetic process (GO:0006744) | 3.00635746 |
| 101 | cardiac muscle contraction (GO:0060048) | 2.99882676 |
| 102 | coenzyme catabolic process (GO:0009109) | 2.98094228 |
| 103 | thioester metabolic process (GO:0035383) | 2.95956053 |
| 104 | acyl-CoA metabolic process (GO:0006637) | 2.95956053 |
| 105 | gluconeogenesis (GO:0006094) | 2.95379378 |
| 106 | neurotransmitter catabolic process (GO:0042135) | 2.94776910 |
| 107 | cardiac muscle cell development (GO:0055013) | 2.92833660 |
| 108 | plasma membrane repair (GO:0001778) | 2.92688774 |
| 109 | translational elongation (GO:0006414) | 2.91179919 |
| 110 | regulation of cholesterol metabolic process (GO:0090181) | 2.90281509 |
| 111 | cellular protein complex disassembly (GO:0043624) | 2.89917344 |
| 112 | fatty acid homeostasis (GO:0055089) | 2.88119788 |
| 113 | small molecule catabolic process (GO:0044282) | 2.87864827 |
| 114 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.87794859 |
| 115 | cotranslational protein targeting to membrane (GO:0006613) | 2.86267228 |
| 116 | protein targeting to ER (GO:0045047) | 2.85913010 |
| 117 | histone-serine phosphorylation (GO:0035404) | 2.84205989 |
| 118 | behavioral response to nicotine (GO:0035095) | 2.82616197 |
| 119 | flavonoid metabolic process (GO:0009812) | 2.80029601 |
| 120 | regulation of histone phosphorylation (GO:0033127) | 2.78397450 |
| 121 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.77786128 |
| 122 | phenol-containing compound catabolic process (GO:0019336) | 2.74657526 |
| 123 | actin-mediated cell contraction (GO:0070252) | 2.74015830 |
| 124 | protein localization to endoplasmic reticulum (GO:0070972) | 2.67703796 |
| 125 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.65655931 |
| 126 | primary alcohol catabolic process (GO:0034310) | 2.64726028 |
| 127 | L-methionine salvage (GO:0071267) | 2.62941919 |
| 128 | L-methionine biosynthetic process (GO:0071265) | 2.62941919 |
| 129 | amino acid salvage (GO:0043102) | 2.62941919 |
| 130 | viral life cycle (GO:0019058) | 2.60326578 |
| 131 | cellular potassium ion homeostasis (GO:0030007) | 2.59030931 |
| 132 | striated muscle contraction (GO:0006941) | 2.58155455 |
| 133 | macroautophagy (GO:0016236) | 2.56413885 |
| 134 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.52932860 |
| 135 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.52239969 |
| 136 | ethanol metabolic process (GO:0006067) | 2.51356685 |
| 137 | chaperone-mediated protein complex assembly (GO:0051131) | 2.50761982 |
| 138 | protein complex disassembly (GO:0043241) | 2.50508226 |
| 139 | mitochondrion morphogenesis (GO:0070584) | 2.47413203 |
| 140 | sodium ion export (GO:0071436) | 2.46622396 |
| 141 | sulfur amino acid biosynthetic process (GO:0000097) | 2.46352757 |
| 142 | drug catabolic process (GO:0042737) | 2.45956387 |
| 143 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.45485032 |
| 144 | regulation of translational fidelity (GO:0006450) | 2.45366510 |
| 145 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.44816355 |
| 146 | axon ensheathment in central nervous system (GO:0032291) | 2.44362351 |
| 147 | central nervous system myelination (GO:0022010) | 2.44362351 |
| 148 | cochlea morphogenesis (GO:0090103) | 2.41846326 |
| 149 | regulation of cellular respiration (GO:0043457) | 2.40295713 |
| 150 | gamma-aminobutyric acid transport (GO:0015812) | 2.39143641 |
| 151 | serine family amino acid biosynthetic process (GO:0009070) | 2.36347833 |
| 152 | skeletal muscle contraction (GO:0003009) | 2.35792243 |
| 153 | methionine biosynthetic process (GO:0009086) | 2.34975922 |
| 154 | macromolecular complex disassembly (GO:0032984) | 2.33438544 |
| 155 | membrane repolarization (GO:0086009) | 2.33053609 |
| 156 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.32846948 |
| 157 | notochord development (GO:0030903) | 2.31423590 |
| 158 | skeletal muscle adaptation (GO:0043501) | 2.30753861 |
| 159 | polyketide metabolic process (GO:0030638) | 2.29801443 |
| 160 | doxorubicin metabolic process (GO:0044598) | 2.29801443 |
| 161 | daunorubicin metabolic process (GO:0044597) | 2.29801443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.82258586 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.46596401 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.01953778 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.68123720 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.29653822 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68007514 |
| 7 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.26186047 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.12845895 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98897384 |
| 10 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.97477183 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.84364508 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.52351408 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.39397777 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36568211 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.30812760 |
| 16 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26109587 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.24801304 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23786426 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.12849892 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12326649 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10921316 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.93815430 |
| 23 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.75561360 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71980263 |
| 25 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.70585378 |
| 26 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.69134633 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67233412 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58881162 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57351542 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56451016 |
| 31 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.56080598 |
| 32 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.55048006 |
| 33 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52568153 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50721957 |
| 35 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.50379357 |
| 36 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.48626264 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.48626264 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47739811 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46259317 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46257402 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44850522 |
| 42 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44022799 |
| 43 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43993807 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.42659853 |
| 45 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.42117662 |
| 46 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41794507 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39818349 |
| 48 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39505443 |
| 49 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35849079 |
| 50 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.29561750 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27742146 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27117341 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27012458 |
| 54 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.25192955 |
| 55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24558500 |
| 56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22691141 |
| 57 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.21843245 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.21843245 |
| 59 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21138415 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20589039 |
| 61 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19613841 |
| 62 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17133032 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15702497 |
| 64 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15366638 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14862123 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14808447 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14389432 |
| 68 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14041638 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13748965 |
| 70 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.10905257 |
| 71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10657265 |
| 72 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.08605973 |
| 73 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06980257 |
| 74 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.06934997 |
| 75 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.06709707 |
| 76 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06499940 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05639207 |
| 78 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04989126 |
| 79 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04149102 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03928456 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03903492 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03830672 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03566234 |
| 84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02630648 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01303957 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.00959548 |
| 87 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00264864 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99661533 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99521278 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99246222 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98289580 |
| 92 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97553937 |
| 93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96502011 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96330061 |
| 95 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96150089 |
| 96 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.95690595 |
| 97 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95400037 |
| 98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95082847 |
| 99 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.94775695 |
| 100 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94329416 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94235797 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94062760 |
| 103 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93711022 |
| 104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93588723 |
| 105 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.93481835 |
| 106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93174877 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92991443 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.92763540 |
| 109 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.92154723 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92038787 |
| 111 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92013914 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91053794 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90670768 |
| 114 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90485025 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90065636 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89759245 |
| 117 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.89738364 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88801566 |
| 119 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.88344934 |
| 120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87743592 |
| 121 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.87451573 |
| 122 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87314629 |
| 123 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87272228 |
| 124 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.87125624 |
| 125 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86585544 |
| 126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86335150 |
| 127 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86333966 |
| 128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86119850 |
| 129 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85645473 |
| 130 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84755356 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84360167 |
| 132 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84339179 |
| 133 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83696101 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82977207 |
| 135 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.82850678 |
| 136 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.82822978 |
| 137 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82811014 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82759838 |
| 139 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.82685704 |
| 140 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82506642 |
| 141 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82226304 |
| 142 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.82138837 |
| 143 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81745732 |
| 144 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.81539592 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81388367 |
| 146 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81249922 |
| 147 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80175473 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.79385476 |
| 149 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77931288 |
| 150 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.77762838 |
| 151 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76955238 |
| 152 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75776020 |
| 153 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75610641 |
| 154 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75469286 |
| 155 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.74718287 |
| 156 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.74018494 |
| 157 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73805560 |
| 158 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72916429 |
| 159 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72682980 |
| 160 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71407816 |
| 161 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70167244 |
| 162 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.70160080 |
| 163 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.69517088 |
| 164 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.68996499 |
| 165 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.68720910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.47233168 |
| 2 | MP0003646_muscle_fatigue | 4.39615986 |
| 3 | MP0005360_urolithiasis | 4.38921818 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.30501738 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.68316075 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.51067664 |
| 7 | MP0003136_yellow_coat_color | 3.50715344 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.26820129 |
| 9 | MP0005365_abnormal_bile_salt | 3.22622418 |
| 10 | MP0000751_myopathy | 2.85677824 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.84387431 |
| 12 | MP0005330_cardiomyopathy | 2.79996552 |
| 13 | MP0004130_abnormal_muscle_cell | 2.73721364 |
| 14 | MP0000749_muscle_degeneration | 2.70299693 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.68453412 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.57920478 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56630320 |
| 18 | MP0005332_abnormal_amino_acid | 2.46749551 |
| 19 | MP0003195_calcinosis | 2.35790882 |
| 20 | MP0009840_abnormal_foam_cell | 2.20934075 |
| 21 | MP0005670_abnormal_white_adipose | 2.18335964 |
| 22 | MP0003252_abnormal_bile_duct | 2.11590259 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.08594776 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.03765264 |
| 25 | MP0004087_abnormal_muscle_fiber | 2.02816129 |
| 26 | MP0005666_abnormal_adipose_tissue | 2.00658237 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.90659710 |
| 28 | MP0002269_muscular_atrophy | 1.87912141 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.87658247 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.86924692 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.79124879 |
| 32 | MP0004043_abnormal_pH_regulation | 1.76363932 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.74769893 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.74289298 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.74189144 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.74189144 |
| 37 | MP0005083_abnormal_biliary_tract | 1.73063192 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.72917272 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.71680787 |
| 40 | MP0003186_abnormal_redox_activity | 1.71187379 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.67696982 |
| 42 | MP0000566_synostosis | 1.61954229 |
| 43 | MP0010630_abnormal_cardiac_muscle | 1.60231725 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.58542491 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.57611164 |
| 46 | MP0001346_abnormal_lacrimal_gland | 1.56506882 |
| 47 | MP0003137_abnormal_impulse_conducting | 1.55793739 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52029067 |
| 49 | MP0006138_congestive_heart_failure | 1.51600167 |
| 50 | MP0000747_muscle_weakness | 1.51478635 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.49897543 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.47805310 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.43573350 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.42672073 |
| 55 | MP0000609_abnormal_liver_physiology | 1.41118056 |
| 56 | MP0002938_white_spotting | 1.40244179 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.39250531 |
| 58 | MP0004233_abnormal_muscle_weight | 1.36815924 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.36370894 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.29221216 |
| 61 | MP0002971_abnormal_brown_adipose | 1.29122999 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.28856139 |
| 63 | MP0005266_abnormal_metabolism | 1.27642165 |
| 64 | MP0000759_abnormal_skeletal_muscle | 1.26797307 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.26083906 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.25579417 |
| 67 | MP0004484_altered_response_of | 1.21644665 |
| 68 | MP0002064_seizures | 1.20249602 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.20031032 |
| 70 | MP0004858_abnormal_nervous_system | 1.15571037 |
| 71 | MP0005369_muscle_phenotype | 1.15507317 |
| 72 | MP0003283_abnormal_digestive_organ | 1.13562021 |
| 73 | MP0009745_abnormal_behavioral_response | 1.12044346 |
| 74 | MP0001485_abnormal_pinna_reflex | 1.11091531 |
| 75 | MP0009046_muscle_twitch | 1.09305682 |
| 76 | MP0000343_altered_response_to | 1.06649379 |
| 77 | MP0001764_abnormal_homeostasis | 1.06406598 |
| 78 | MP0002078_abnormal_glucose_homeostasis | 1.02374341 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.02081460 |
| 80 | MP0003828_pulmonary_edema | 1.01934147 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.01377918 |
| 82 | MP0003315_abnormal_perineum_morphology | 0.99892582 |
| 83 | MP0003890_abnormal_embryonic-extraembry | 0.99334544 |
| 84 | MP0005451_abnormal_body_composition | 0.99316293 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.98446599 |
| 86 | MP0003959_abnormal_lean_body | 0.97209964 |
| 87 | MP0002108_abnormal_muscle_morphology | 0.96698438 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.96152299 |
| 89 | MP0004142_abnormal_muscle_tone | 0.93617036 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 0.92516538 |
| 91 | MP0001756_abnormal_urination | 0.91938598 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.91671609 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.91031535 |
| 94 | MP0004085_abnormal_heartbeat | 0.90676397 |
| 95 | MP0004885_abnormal_endolymph | 0.90377563 |
| 96 | MP0000534_abnormal_ureter_morphology | 0.87571098 |
| 97 | MP0000598_abnormal_liver_morphology | 0.87215337 |
| 98 | MP0004147_increased_porphyrin_level | 0.87116920 |
| 99 | MP0005165_increased_susceptibility_to | 0.86394619 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.86097466 |
| 101 | MP0005535_abnormal_body_temperature | 0.84347457 |
| 102 | MP0004133_heterotaxia | 0.82545559 |
| 103 | MP0000579_abnormal_nail_morphology | 0.81384600 |
| 104 | MP0002127_abnormal_cardiovascular_syste | 0.81285885 |
| 105 | MP0004270_analgesia | 0.81182883 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.79758982 |
| 107 | MP0005187_abnormal_penis_morphology | 0.78833462 |
| 108 | MP0003879_abnormal_hair_cell | 0.78697915 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.78548694 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.77621467 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.77321040 |
| 112 | MP0009053_abnormal_anal_canal | 0.77087018 |
| 113 | MP0005334_abnormal_fat_pad | 0.75417215 |
| 114 | MP0000762_abnormal_tongue_morphology | 0.74592634 |
| 115 | MP0002160_abnormal_reproductive_system | 0.74419415 |
| 116 | MP0003632_abnormal_nervous_system | 0.72926521 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72111881 |
| 118 | MP0003942_abnormal_urinary_system | 0.70739890 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.70426246 |
| 120 | MP0002970_abnormal_white_adipose | 0.69546315 |
| 121 | MP0005171_absent_coat_pigmentation | 0.69539678 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.69343155 |
| 123 | MP0004742_abnormal_vestibular_system | 0.68657874 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.68480077 |
| 125 | MP0009115_abnormal_fat_cell | 0.67629425 |
| 126 | MP0000733_abnormal_muscle_development | 0.65341910 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.65277024 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.65093986 |
| 129 | MP0000266_abnormal_heart_morphology | 0.64802410 |
| 130 | MP0000026_abnormal_inner_ear | 0.64467593 |
| 131 | MP0005503_abnormal_tendon_morphology | 0.64385032 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.64009616 |
| 133 | MP0008569_lethality_at_weaning | 0.63851961 |
| 134 | MP0003011_delayed_dark_adaptation | 0.63528781 |
| 135 | MP0002272_abnormal_nervous_system | 0.62152297 |
| 136 | MP0002572_abnormal_emotion/affect_behav | 0.61993511 |
| 137 | MP0000013_abnormal_adipose_tissue | 0.60709914 |
| 138 | MP0009763_increased_sensitivity_to | 0.58900311 |
| 139 | MP0003279_aneurysm | 0.58002494 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.57672462 |
| 141 | MP0003566_abnormal_cell_adhesion | 0.55808188 |
| 142 | MP0008469_abnormal_protein_level | 0.55380095 |
| 143 | MP0000358_abnormal_cell_content/ | 0.54905694 |
| 144 | MP0009697_abnormal_copulation | 0.54686653 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.54241484 |
| 146 | MP0006054_spinal_hemorrhage | 0.54064071 |
| 147 | MP0001661_extended_life_span | 0.53578629 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.52606771 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.49152872 |
| 150 | MP0002128_abnormal_blood_circulation | 0.48951314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 4.75609124 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.71036596 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.62271656 |
| 4 | Nemaline bodies (HP:0003798) | 4.46806518 |
| 5 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.40405218 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.39661561 |
| 7 | Hepatic necrosis (HP:0002605) | 4.34021572 |
| 8 | Ketoacidosis (HP:0001993) | 4.26223582 |
| 9 | Hyperglycinuria (HP:0003108) | 4.19873275 |
| 10 | Sudden death (HP:0001699) | 4.17302580 |
| 11 | Ketosis (HP:0001946) | 4.14150966 |
| 12 | Hyperammonemia (HP:0001987) | 4.12227849 |
| 13 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.10389215 |
| 14 | Dicarboxylic aciduria (HP:0003215) | 4.10389215 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.97212720 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.95039720 |
| 17 | Acute encephalopathy (HP:0006846) | 3.94585307 |
| 18 | Exercise-induced muscle cramps (HP:0003710) | 3.94026751 |
| 19 | Cerebral edema (HP:0002181) | 3.92368663 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.89126853 |
| 21 | Ventricular tachycardia (HP:0004756) | 3.77719325 |
| 22 | Generalized aminoaciduria (HP:0002909) | 3.72886097 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 3.70462224 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.68670692 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.68670692 |
| 26 | Hepatocellular necrosis (HP:0001404) | 3.53163437 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.45555226 |
| 28 | Type 1 muscle fiber predominance (HP:0003803) | 3.45291087 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.42453092 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41208032 |
| 31 | Abnormal number of erythroid precursors (HP:0012131) | 3.31228683 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 3.30396354 |
| 33 | Increased muscle lipid content (HP:0009058) | 3.30037971 |
| 34 | Large for gestational age (HP:0001520) | 3.28900645 |
| 35 | Xanthomatosis (HP:0000991) | 3.21225981 |
| 36 | Hyperglycinemia (HP:0002154) | 3.19235885 |
| 37 | Lethargy (HP:0001254) | 3.17056476 |
| 38 | Birth length less than 3rd percentile (HP:0003561) | 3.16580864 |
| 39 | Nausea (HP:0002018) | 3.16213863 |
| 40 | * Palpitations (HP:0001962) | 3.16066520 |
| 41 | Lipoatrophy (HP:0100578) | 3.11775327 |
| 42 | Mitochondrial inheritance (HP:0001427) | 3.10350186 |
| 43 | Lactic acidosis (HP:0003128) | 3.09591706 |
| 44 | Increased CSF lactate (HP:0002490) | 3.08619629 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 3.01702064 |
| 46 | Right ventricular cardiomyopathy (HP:0011663) | 3.01177998 |
| 47 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.00803072 |
| 48 | Proximal tubulopathy (HP:0000114) | 2.98888101 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.98341284 |
| 50 | Muscle fiber splitting (HP:0003555) | 2.97923675 |
| 51 | Intrahepatic cholestasis (HP:0001406) | 2.96902899 |
| 52 | Metabolic acidosis (HP:0001942) | 2.96049350 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.93656007 |
| 54 | Abnormality of glycolysis (HP:0004366) | 2.93656007 |
| 55 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.92567797 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.92567797 |
| 57 | Dilated cardiomyopathy (HP:0001644) | 2.90614992 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.86184270 |
| 59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.76905571 |
| 60 | Myopathic facies (HP:0002058) | 2.73840403 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.72089911 |
| 62 | Atrial fibrillation (HP:0005110) | 2.71704736 |
| 63 | Vomiting (HP:0002013) | 2.70667485 |
| 64 | Hyperlipoproteinemia (HP:0010980) | 2.70210020 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.69305485 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67791615 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65736850 |
| 68 | Respiratory failure (HP:0002878) | 2.65695741 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.61882428 |
| 70 | Deep venous thrombosis (HP:0002625) | 2.61846969 |
| 71 | Gout (HP:0001997) | 2.60969529 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 2.56557632 |
| 73 | Hyperalaninemia (HP:0003348) | 2.56557632 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.56557632 |
| 75 | Hypolipoproteinemia (HP:0010981) | 2.56073206 |
| 76 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.55351255 |
| 77 | Hyporeflexia of lower limbs (HP:0002600) | 2.54813032 |
| 78 | Hypobetalipoproteinemia (HP:0003563) | 2.54159435 |
| 79 | Primary atrial arrhythmia (HP:0001692) | 2.49620433 |
| 80 | Exercise intolerance (HP:0003546) | 2.48706455 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 2.48312458 |
| 82 | Supraventricular tachycardia (HP:0004755) | 2.47049913 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46092713 |
| 84 | Supraventricular arrhythmia (HP:0005115) | 2.41837658 |
| 85 | EMG: myopathic abnormalities (HP:0003458) | 2.41826933 |
| 86 | Glycosuria (HP:0003076) | 2.40909475 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.40909475 |
| 88 | Increased serum lactate (HP:0002151) | 2.39612533 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.37230691 |
| 90 | Late onset (HP:0003584) | 2.36675671 |
| 91 | Subaortic stenosis (HP:0001682) | 2.34053372 |
| 92 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.34053372 |
| 93 | Muscle stiffness (HP:0003552) | 2.32642570 |
| 94 | Increased connective tissue (HP:0009025) | 2.31947341 |
| 95 | Methylmalonic aciduria (HP:0012120) | 2.31699755 |
| 96 | Congenital, generalized hypertrichosis (HP:0004540) | 2.31322333 |
| 97 | Abnormality of purine metabolism (HP:0004352) | 2.30552488 |
| 98 | Delayed CNS myelination (HP:0002188) | 2.30369024 |
| 99 | Syncope (HP:0001279) | 2.29366732 |
| 100 | Lipid accumulation in hepatocytes (HP:0006561) | 2.27553273 |
| 101 | Rimmed vacuoles (HP:0003805) | 2.25771849 |
| 102 | Type II lissencephaly (HP:0007260) | 2.24895142 |
| 103 | Multiple enchondromatosis (HP:0005701) | 2.24534673 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.22568462 |
| 105 | Macrocytic anemia (HP:0001972) | 2.21422605 |
| 106 | Atrioventricular block (HP:0001678) | 2.20937885 |
| 107 | Concave nail (HP:0001598) | 2.19588976 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18370239 |
| 109 | Increased purine levels (HP:0004368) | 2.16863826 |
| 110 | Hyperuricemia (HP:0002149) | 2.16863826 |
| 111 | CNS demyelination (HP:0007305) | 2.16329551 |
| 112 | Ventricular arrhythmia (HP:0004308) | 2.15692531 |
| 113 | Cholelithiasis (HP:0001081) | 2.10677033 |
| 114 | Heart block (HP:0012722) | 2.10510699 |
| 115 | Renal cortical cysts (HP:0000803) | 2.09073952 |
| 116 | Bundle branch block (HP:0011710) | 2.06012416 |
| 117 | Metabolic alkalosis (HP:0200114) | 2.04773185 |
| 118 | Breast hypoplasia (HP:0003187) | 2.01472821 |
| 119 | Skin nodule (HP:0200036) | 2.01052280 |
| 120 | Abnormal atrioventricular conduction (HP:0005150) | 1.98187587 |
| 121 | Hypoplastic ischia (HP:0003175) | 1.97181182 |
| 122 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96036550 |
| 123 | Alkalosis (HP:0001948) | 1.94585237 |
| 124 | Distal lower limb muscle weakness (HP:0009053) | 1.93864365 |
| 125 | Generalized muscle weakness (HP:0003324) | 1.92866698 |
| 126 | Partial agenesis of the corpus callosum (HP:0001338) | 1.91807898 |
| 127 | Myotonia (HP:0002486) | 1.85804721 |
| 128 | Hyperacusis (HP:0010780) | 1.85082608 |
| 129 | Dysmetric saccades (HP:0000641) | 1.84299912 |
| 130 | Neck muscle weakness (HP:0000467) | 1.81636277 |
| 131 | Frequent falls (HP:0002359) | 1.80201660 |
| 132 | Distal arthrogryposis (HP:0005684) | 1.78708581 |
| 133 | Progressive muscle weakness (HP:0003323) | 1.78570007 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77635242 |
| 135 | Ulnar deviation of the wrist (HP:0003049) | 1.76748430 |
| 136 | Decreased subcutaneous fat (HP:0001002) | 1.74339527 |
| 137 | Severe muscular hypotonia (HP:0006829) | 1.74227258 |
| 138 | Hyperkalemia (HP:0002153) | 1.72895492 |
| 139 | Hypoplasia of the pons (HP:0012110) | 1.72842737 |
| 140 | Reduced antithrombin III activity (HP:0001976) | 1.72694248 |
| 141 | Broad metatarsal (HP:0001783) | 1.71515780 |
| 142 | Tubular atrophy (HP:0000092) | 1.71399917 |
| 143 | Calcaneovalgus deformity (HP:0001848) | 1.70729617 |
| 144 | Prolonged partial thromboplastin time (HP:0003645) | 1.70661014 |
| 145 | Posterior embryotoxon (HP:0000627) | 1.70169585 |
| 146 | Abnormality of the pons (HP:0007361) | 1.70052096 |
| 147 | Back pain (HP:0003418) | 1.68891836 |
| 148 | Prominent supraorbital ridges (HP:0000336) | 1.68698941 |
| 149 | Abnormality of the diencephalon (HP:0010662) | 1.68476859 |
| 150 | Abnormality of the ischium (HP:0003174) | 1.66695164 |
| 151 | Hyperaldosteronism (HP:0000859) | 1.65022283 |
| 152 | Hypokalemia (HP:0002900) | 1.64139902 |
| 153 | Abnormality of the vitreous humor (HP:0004327) | 1.62547638 |
| 154 | Confusion (HP:0001289) | 1.59699170 |
| 155 | Patellar aplasia (HP:0006443) | 1.59587975 |
| 156 | Spastic tetraparesis (HP:0001285) | 1.59327826 |
| 157 | Reticulocytopenia (HP:0001896) | 1.59115731 |
| 158 | Abnormality of potassium homeostasis (HP:0011042) | 1.58029679 |
| 159 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.57125790 |
| 160 | Absent/shortened dynein arms (HP:0200106) | 1.57125790 |
| 161 | Clumsiness (HP:0002312) | 1.56559075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.22097524 |
| 2 | TRIB3 | 4.01263590 |
| 3 | PNCK | 3.94327401 |
| 4 | TTN | 3.65843392 |
| 5 | PDK3 | 3.40670659 |
| 6 | PDK4 | 3.40670659 |
| 7 | PKN2 | 3.20547249 |
| 8 | OBSCN | 3.07852471 |
| 9 | MAPK15 | 3.03419323 |
| 10 | MYLK | 2.86934892 |
| 11 | NEK1 | 2.83033389 |
| 12 | PHKG2 | 2.61560409 |
| 13 | PHKG1 | 2.61560409 |
| 14 | NME2 | 2.56656582 |
| 15 | LMTK2 | 2.48505870 |
| 16 | ERN1 | 2.26934234 |
| 17 | ICK | 2.23621690 |
| 18 | ACVR1B | 2.14449571 |
| 19 | FLT3 | 2.05714539 |
| 20 | EEF2K | 2.02254184 |
| 21 | VRK2 | 1.91827912 |
| 22 | PDK2 | 1.91389892 |
| 23 | MAP3K9 | 1.90433152 |
| 24 | PINK1 | 1.88298610 |
| 25 | ADRBK2 | 1.86155201 |
| 26 | BMPR1B | 1.78179331 |
| 27 | WNK4 | 1.72349655 |
| 28 | KSR2 | 1.71298576 |
| 29 | WEE1 | 1.60925461 |
| 30 | TIE1 | 1.51634306 |
| 31 | LATS1 | 1.47262022 |
| 32 | PIK3CA | 1.40830412 |
| 33 | NEK9 | 1.40819306 |
| 34 | MAP2K3 | 1.39594228 |
| 35 | CDK12 | 1.39243948 |
| 36 | KDR | 1.35180398 |
| 37 | STK38L | 1.33045700 |
| 38 | CAMK1D | 1.32130566 |
| 39 | ILK | 1.30183988 |
| 40 | STK24 | 1.29873970 |
| 41 | SIK1 | 1.28601270 |
| 42 | NTRK1 | 1.24167425 |
| 43 | DAPK2 | 1.23978532 |
| 44 | MUSK | 1.18942847 |
| 45 | EPHA2 | 1.17368892 |
| 46 | MAP3K10 | 1.16583895 |
| 47 | DMPK | 1.16566340 |
| 48 | LRRK2 | 1.10231398 |
| 49 | MAPKAPK5 | 1.09834318 |
| 50 | NTRK3 | 1.07638012 |
| 51 | MARK1 | 1.07329206 |
| 52 | ARAF | 1.07230159 |
| 53 | MAPKAPK3 | 1.06898957 |
| 54 | MAP3K11 | 1.04663651 |
| 55 | RPS6KB2 | 1.03145043 |
| 56 | FGFR4 | 1.02878302 |
| 57 | NEK2 | 0.95651553 |
| 58 | OXSR1 | 0.94883395 |
| 59 | CAMK1G | 0.94851004 |
| 60 | MAP3K3 | 0.92933551 |
| 61 | DAPK3 | 0.91535644 |
| 62 | MAPK11 | 0.87373786 |
| 63 | MAP3K5 | 0.84465670 |
| 64 | PRKAA2 | 0.82877176 |
| 65 | PIK3CG | 0.82656925 |
| 66 | LIMK1 | 0.81941372 |
| 67 | PTK6 | 0.81624740 |
| 68 | PAK2 | 0.81494222 |
| 69 | MAP3K2 | 0.77991603 |
| 70 | CAMKK2 | 0.76399651 |
| 71 | EIF2AK1 | 0.75230364 |
| 72 | PRKAA1 | 0.70510333 |
| 73 | MAP3K7 | 0.70191501 |
| 74 | PRKD1 | 0.68831721 |
| 75 | INSRR | 0.68562069 |
| 76 | NME1 | 0.65626677 |
| 77 | ADRBK1 | 0.65136534 |
| 78 | MAPK12 | 0.63936395 |
| 79 | STK4 | 0.63323271 |
| 80 | CAMK2D | 0.62933250 |
| 81 | ABL2 | 0.61804697 |
| 82 | PDGFRA | 0.61770773 |
| 83 | TESK1 | 0.61031928 |
| 84 | RIPK1 | 0.60010342 |
| 85 | PAK3 | 0.59868683 |
| 86 | MST1R | 0.59823387 |
| 87 | TRPM7 | 0.59170548 |
| 88 | PIM2 | 0.58981491 |
| 89 | CDK3 | 0.56643315 |
| 90 | SIK2 | 0.56284532 |
| 91 | WNK1 | 0.55017890 |
| 92 | CAMK1 | 0.54361786 |
| 93 | CAMK2G | 0.52265126 |
| 94 | TAOK2 | 0.51851543 |
| 95 | TGFBR2 | 0.51174830 |
| 96 | TESK2 | 0.51108680 |
| 97 | PRKG2 | 0.50922455 |
| 98 | PAK4 | 0.49906786 |
| 99 | ROCK1 | 0.48841956 |
| 100 | MAP3K13 | 0.48370779 |
| 101 | TBK1 | 0.48311949 |
| 102 | WNK3 | 0.48000830 |
| 103 | LATS2 | 0.47379258 |
| 104 | CAMK2A | 0.45751604 |
| 105 | MTOR | 0.45651625 |
| 106 | VRK1 | 0.45453708 |
| 107 | TLK1 | 0.45225797 |
| 108 | CAMK2B | 0.43332232 |
| 109 | PRKACG | 0.43311746 |
| 110 | YES1 | 0.43276599 |
| 111 | PRKCG | 0.42671083 |
| 112 | MET | 0.40721611 |
| 113 | TTK | 0.40327967 |
| 114 | TYRO3 | 0.40051556 |
| 115 | CDK4 | 0.39521443 |
| 116 | CDC42BPA | 0.39311518 |
| 117 | STK39 | 0.39030808 |
| 118 | AKT2 | 0.38515410 |
| 119 | MAP3K8 | 0.38086998 |
| 120 | MAP2K6 | 0.37983002 |
| 121 | BUB1 | 0.36565210 |
| 122 | DYRK3 | 0.36019235 |
| 123 | DYRK1B | 0.34837393 |
| 124 | CAMK4 | 0.34189162 |
| 125 | EPHB2 | 0.34157140 |
| 126 | CAMKK1 | 0.33217993 |
| 127 | PTK2 | 0.33095219 |
| 128 | ERBB4 | 0.32783995 |
| 129 | CDK7 | 0.32697879 |
| 130 | ZAK | 0.32324898 |
| 131 | SMG1 | 0.32268674 |
| 132 | CSNK1E | 0.32119199 |
| 133 | STK10 | 0.31482688 |
| 134 | BRAF | 0.30220406 |
| 135 | PDPK1 | 0.30200122 |
| 136 | STK16 | 0.29390230 |
| 137 | MAP2K1 | 0.28358103 |
| 138 | PBK | 0.26862289 |
| 139 | GRK7 | 0.26511522 |
| 140 | RPS6KC1 | 0.26368664 |
| 141 | RPS6KL1 | 0.26368664 |
| 142 | TGFBR1 | 0.25977216 |
| 143 | BRSK2 | 0.25933408 |
| 144 | GRK1 | 0.25905960 |
| 145 | STK38 | 0.25900086 |
| 146 | MAPK4 | 0.25329144 |
| 147 | CHEK2 | 0.25180402 |
| 148 | RPS6KA3 | 0.24316314 |
| 149 | GSK3A | 0.22424579 |
| 150 | RPS6KA4 | 0.21783688 |
| 151 | MAP2K4 | 0.21210609 |
| 152 | RPS6KA6 | 0.20728120 |
| 153 | JAK2 | 0.19811304 |
| 154 | RPS6KA1 | 0.18710659 |
| 155 | PRKACA | 0.18409389 |
| 156 | MAP2K2 | 0.18134851 |
| 157 | PRKACB | 0.17196854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.48312633 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.83835933 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.52780151 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.36620219 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.20547503 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.12314288 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01070914 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.51848614 |
| 9 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.50034686 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41240477 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20673620 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.12922790 |
| 13 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.12922138 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.10531766 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07876427 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05539884 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01499333 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94042936 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.91140812 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87548897 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80730905 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.72238251 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68903925 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66031776 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65433963 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.62753312 |
| 27 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56701858 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55849621 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55508876 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.52877429 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.45795456 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43103516 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33351234 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31834631 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.31030963 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22592566 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22205685 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20694042 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18377096 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15262012 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10387923 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09887002 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08778889 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03362975 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98555304 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97732526 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97236505 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95449116 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93732085 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91070798 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90165572 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90140824 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90034623 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89959210 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88944739 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88826054 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84542505 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84409575 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80890678 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.79612045 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.75965661 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75941164 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75500472 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72712415 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.70380673 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70107843 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69433170 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.69279995 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68705810 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.68563858 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68536938 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.67168499 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63550804 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62140283 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59787655 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56032943 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55925878 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.55366800 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.53680481 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51555189 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.51138331 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49725030 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45403103 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43437513 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42299035 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42016647 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.41172965 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.40551276 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38518584 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37495638 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36132844 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35910720 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.35427713 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35302260 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34926017 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33359796 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32893645 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.32866252 |
| 99 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32590383 |
| 100 | RNA polymerase_Homo sapiens_hsa03020 | 0.32574638 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31696364 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29903562 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.28578978 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27804179 |
| 105 | Ribosome_Homo sapiens_hsa03010 | 0.23729787 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19814899 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.18380892 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16595715 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12667196 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11919733 |
| 111 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08231323 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.03409528 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02586562 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00143652 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0538852 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0519134 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0479295 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0359492 |
| 119 | Protein export_Homo sapiens_hsa03060 | -0.0239713 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0187994 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0005286 |

